Schering/FDA Relations Are Priority For Hassan: GMPs, Asmanex On Agenda
Executive Summary
Schering-Plough CEO Fred Hassan hopes his credibility with FDA can help in discussions over the company's GMP work plan and the delayed Asmanex approval
You may also be interested in...
Schering GMP Work Plan Is One-Third Complete; Toughest Battles Lie Ahead
The remaining two-thirds of Schering-Plough's GMP work plan contain the most challenging requirements under the company's 2002 manufacturing consent decree, CEO Fred Hassan told analysts Nov. 18
Schering Reinvesting In Sales After Cutbacks; “Selective” Support For Zetia
Schering-Plough will begin to reverse cutbacks in its primary care sales force, CEO Fred Hassan told investors during a conference call July 23
Schering Reinvesting In Sales After Cutbacks; “Selective” Support For Zetia
Schering-Plough will begin to reverse cutbacks in its primary care sales force, CEO Fred Hassan told investors during a conference call July 23